Tuesday - December 24, 2024

Treating Refractory Migraine

Copyright © Targeted News Service 2024
2024-11-12
ALEXANDRIA, Virginia, Nov. 12 -- TEVA PHARMACEUTICALS INTERNATIONAL GMBH, Jona, Switzerland has been assigned a patent (No. US 12139528 B2, initially filed Feb. 17, 2023) developed by Marcelo Bigal, Doylestown, Pennsylvania, and Ernesto Aycardi, Andover, Massachusetts, for "Treating refractory migraine." . . .

Information Request Form

Name:
Category that best fits the type
of business or agency you are
affiliated with:		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:
I'd like to have a copy of this article mailed to me.
To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest.
If you select them please specify your keywords in the box below:
If we need to contact you please specify your preferred contact method.
Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Copyright Targeted News Service 2024